Emcure Pharmaceuticals Quarterly Results for Trading Insights
In Mar 2026, Emcure Pharmaceuticals (EMCURE) reported revenue ₹2,484 Cr and net profit ₹244 Cr — revenue +17.1% YoY. For annual financials, live price and key ratios, visit Emcure Pharmaceuticals share price today.
EMCURE Quarterly Results — Revenue, Profit & EPS Highlights
Emcure Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Browse EMCURE income statement for revenue, profit, balance sheet and cash flow data.
- Revenue of ₹2,484 Cr in Mar 2026 (+9.3% vs Sept 2025, +17.1% vs Mar 2025)
- Net Profit of ₹244 Cr in Mar 2026 (-2.8% vs Sept 2025, +23.9% vs Mar 2025)
- EBITDA of ₹494 Cr in Mar 2026 (+3.1% vs Sept 2025)
- Operating Margin of 19.0% in Mar 2026 (-2.0pp vs Sept 2025)
- Earnings Per Share of ₹12.84 in Mar 2026 (-0.1% vs Sept 2025)
Emcure Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS
EMCURE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,484 | 2,273 | 2,121 | 2,104 | 2,365 | 9.3% | 17.1% |
| Net Profit (₹ Cr) | 244 | 251 | 197 | 215 | 231 | - | - |
| EBITDA (₹ Cr) | 494 | 479 | 397 | 417 | 456 | - | - |
| EPS (₹) | 12.84 | 12.85 | 9.97 | 10.92 | 12.16 | - | - |
| Operating Margin (%) | 19.0% | 21.0% | 19.0% | 20.0% | 19.0% | - | - |
EMCURE Share Price Trend — 1-Year Movement Across Quarterly Results
Emcure Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore EMCURE price trends to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
EMCURE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Emcure Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹454,122.13 Cr | 1904.8 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 168.6 |
|
Divis Laboratories
Mar 2026 |
₹174,081.02 Cr | 6757.0 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 238.7 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹161,380.94 Cr | 4768.3 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 414.3 |
|
Cipla
Mar 2026 |
₹117,800.00 Cr | 1458.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 212.3 |
|
Dr Reddys Laborator…
Mar 2026 |
₹114,691.88 Cr | 1374.1 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 518.5 |
All amounts in ₹ Crores